<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04792814</url>
  </required_header>
  <id_info>
    <org_study_id>IN-MAT_RAP_01</org_study_id>
    <nct_id>NCT04792814</nct_id>
  </id_info>
  <brief_title>Cell Salvage and Retrograde Autologous Priming</brief_title>
  <official_title>Intraoperative Cell Salvage and Retrograde Autologous Priming in Patients Undergoing Isolated Coronary Bypass Grafting and Conventional Aortic Valve Replacement.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Schleswig-Holstein</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Schleswig-Holstein</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In recent years Patient Blood Management (PBM) has developed into a multifactorial and&#xD;
      interdisciplinary concept that focuses on individualized and optimized hemotherapy. Of&#xD;
      course, this also applies to the cardiac surgery area (1). In this context, the quality of&#xD;
      the intraoperative PBM can be represented by patients scheduled for isolated coronary artery&#xD;
      bypass grafting (CABG) and isolated aortic valve replacement (AVR). In a prospective,&#xD;
      observational &quot;before-and-after&quot; protocol, the investigators analysed the impact of the&#xD;
      combined use of retrograde autologous priming (RAP) and cell salvage on intraoperative usage&#xD;
      of red blood cell concentrates (RBC) (2).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      200 patients (CABG or AVR) will be monitored using local standard of care in these patients&#xD;
      without cell salvage and RAP (control group, CG), followed by 200 patients with cell salvage&#xD;
      and RAP (study group, SG). Both groups are defined by elective surgery and hemodynamically&#xD;
      stable patients prior to the onset of the cardiopulmonary bypass (CPB). Based on our own data&#xD;
      and current data from the literature, the investigators assume that the use of MAT in&#xD;
      combination with RAP leads to at least an intraoperative reduction of the erythrocyte&#xD;
      consumption of 15%. Consequently, the investigators calculated a case number of approximately&#xD;
      200 patients per group.&#xD;
&#xD;
      The study is set up with a control group under previous standard therapy. The data is&#xD;
      recorded and analyzed descriptively. Qualitative comparisons will be made in the discussion&#xD;
      of previously published data.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2018</start_date>
  <completion_date type="Actual">October 31, 2019</completion_date>
  <primary_completion_date type="Actual">October 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>number of red blood cell concentrates</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>use of RBC</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative complications</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>acute renal failure, pulmonary edema, pneumonia, wound infection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of stay in hospital</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>time in hospital after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospital mortality</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>hospital mortality</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">200</enrollment>
  <condition>Surgery</condition>
  <condition>Hemodynamic Instability</condition>
  <arm_group>
    <arm_group_label>MAT-RAP group</arm_group_label>
    <description>MAT and RAP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>historical group</arm_group_label>
    <description>standard procedure</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        heart surgery patients (CABG and aortic valve replacement)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  scheduled for cardiac surgery&#xD;
&#xD;
          -  informed written consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  rejection by the patient&#xD;
&#xD;
          -  switching to another procedure&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jochen Renner, Prof. Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>UKSH, Campus Kiel</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universit채tsklinikum Schleswig-Holstein Campus Kiel - Klinik f체r An채sthesiologie und Operative Intensivmedizin</name>
      <address>
        <city>Kiel</city>
        <state>Deutschland (deu)</state>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GERMANY - Universit채tsklinikum Schleswig-Holstein</name>
      <address>
        <city>Kiel</city>
        <state>Schleswig-Holstein</state>
        <zip>24109</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Pagano D, Milojevic M, Meesters MI, Benedetto U, Bolliger D, von Heymann C, Jeppsson A, Koster A, Osnabrugge RL, Ranucci M, Ravn HB, Vonk ABA, Wahba A, Boer C. 2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery. Eur J Cardiothorac Surg. 2018 Jan 1;53(1):79-111. doi: 10.1093/ejcts/ezx325.</citation>
    <PMID>29029100</PMID>
  </reference>
  <reference>
    <citation>Meybohm P, Choorapoikayil S, Wessels A, Herrmann E, Zacharowski K, Spahn DR. Washed cell salvage in surgical patients: A review and meta-analysis of prospective randomized trials under PRISMA. Medicine (Baltimore). 2016 Aug;95(31):e4490. doi: 10.1097/MD.0000000000004490. Review. Erratum in: Medicine (Baltimore). 2018 Apr;97(17):e0640.</citation>
    <PMID>27495095</PMID>
  </reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>December 17, 2020</study_first_submitted>
  <study_first_submitted_qc>March 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 11, 2021</study_first_posted>
  <last_update_submitted>March 10, 2021</last_update_submitted>
  <last_update_submitted_qc>March 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Schleswig-Holstein</investigator_affiliation>
    <investigator_full_name>Dr. Jochen Renner</investigator_full_name>
    <investigator_title>Prof. Dr. med. Jochen Renner</investigator_title>
  </responsible_party>
  <keyword>cell salvage</keyword>
  <keyword>length of stay in hospital</keyword>
  <keyword>mortality</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

